NTLA : Intellia Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $15.45 | $13.8 | $16.85 | 12.9% |
| 2027 | $17.41 | $17.07 | $17.61 | 27.25% |
| 2028 | $17.87 | $17.65 | $18.03 | 30.63% |
| 2029 | $18.15 | $18.04 | $18.25 | 32.7% |
| 2030 | $18.3 | $18.26 | $18.33 | 33.74% |
| 2031 | $18.31 | $18.13 | $18.34 | 33.84% |
| 2032 | $16.92 | $16.28 | $17.97 | 23.67% |
| 2033 | $14.95 | $14.02 | $16.12 | 9.26% |
| 2034 | $12.75 | $11.47 | $13.88 | -6.83% |
| 2035 | $9.94 | $8.95 | $11.19 | -27.34% |
| 2036 | $8.56 | $8.32 | $8.81 | -37.41% |
The 20 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$26.5 with a high forecast of $58.0 and a low forecast of $9.0.
The average Intellia Therapeutics stock forecast represents a 93.71%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast for 2026, 7 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $15.45, a high forecast of $16.85, and a low forecast of $13.8.
The average Intellia Therapeutics stock forecast 2026 represents a 12.9%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Intellia Therapeutics stock
forecast of $17.41, a high forecast of $17.61, and a low forecast of $17.07.
The average Intellia Therapeutics stock forecast 2027 represents a 27.25%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Intellia Therapeutics stock
forecast of $18.15, a high forecast of $18.25, and a low forecast of $18.04.
The average Intellia Therapeutics stock forecast 2029 represents a 32.7%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $18.31, a high forecast of $18.34, and a low forecast of $18.13.
The average Intellia Therapeutics stock forecast 2031 represents a 33.84%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast 2032, 12 predictions are offered for each month of 2032 with average Intellia Therapeutics stock
forecast of $16.92, a high forecast of $17.97, and a low forecast of $16.28.
The average Intellia Therapeutics stock forecast 2032 represents a 23.67%
increase from the last price of $13.6800003051758.
For Intellia Therapeutics stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average Intellia Therapeutics stock
forecast of $8.56, a high forecast of $8.81, and a low forecast of $8.32.
The average Intellia Therapeutics stock forecast 2036 represents a -37.41%
decrease from the last price of $13.6800003051758.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $26.5, and this show a 9.65% increase in average from the prior price target of the each prediction. Also, this average forecast of $26.5 represents a 19.1% increase from the past average forecast of $22.25, 6 months ago from 26 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-13 | HC Wainwright & Co. | $30.0000 | $25.0000 | Buy |
| 2026-05-13 | Bernstein | $13.0000 | $17.0000 | Market Perform |
| 2026-05-12 | Wedbush | $12 | $12.0000 | Neutral |
| 2026-05-12 | Canaccord Genuity | $58.0000 | $49.0000 | Buy |
| 2026-04-28 | Citizens | $28.0000 | $30.0000 | Market Outperform |
| 2026-04-28 | Morgan Stanley | $11.00 | $15.0000 | Equal-Weight |
| 2026-04-28 | Goldman Sachs | $8.0000 | $9.0000 | Sell |
| 2026-04-28 | Canaccord Genuity | $48.00 | $58.0000 | Buy |
| 2026-04-27 | Baird | $7.0000 | $13.0000 | Neutral |
| 2026-04-27 | Chardan Capital | $27.0000 | $30.0000 | Buy |
| 2026-03-04 | Jones Trading | $29.0000 | Buy | |
| 2026-03-03 | Citizens | $21.00 | $28.0000 | Market Outperform |
| 2026-03-03 | Wells Fargo | $12.00 | $15.0000 | Equal-Weight |
| 2026-03-03 | RBC Capital | $9.00 | $15.0000 | Sector Perform |
| 2026-03-03 | Leerink Partners | $27.0000 | $29.0000 | Outperform |
| 2026-03-03 | Canaccord Genuity | $54.00 | $48.0000 | Buy |
| 2026-03-03 | HC Wainwright & Co. | $25.00 | $30.0000 | Buy |
| 2026-03-02 | Chardan Capital | $26.0000 | $27 | Buy |
| 2026-02-27 | Chardan Capital | $26.0000 | $26 | Buy |
| 2026-01-28 | HC Wainwright & Co. | $15.00 | $25.0000 | Buy |
| 2025-11-12 | Wolfe Research | Peer Perform | ||
| 2025-11-11 | Jones Trading | Hold | ||
| 2025-11-11 | Evercore ISI Group | $17.0000 | $8.0000 | In-Line |
| 2025-11-10 | Truist Securities | $25.0000 | $14 | Buy |
| 2025-11-10 | HC Wainwright & Co. | $18.00 | $15.0000 | Buy |
| 2025-11-07 | JP Morgan | $12.0000 | $5.0000 | Underweight |
| 2025-11-07 | Chardan Capital | $48.0000 | $26 | Buy |
| 2025-11-07 | RBC Capital | $14.00 | $9.0000 | Sector Perform |
| 2025-11-07 | Wells Fargo | $17.0000 | $12.0000 | Equal-Weight |
| 2025-11-07 | Barclays | $24.00 | $14.0000 | Overweight |
| 2025-11-07 | Wedbush | $9.0000 | $7.0000 | Neutral |
| 2025-11-07 | Citizens | $29.0000 | $21.0000 | Market Outperform |
| 2025-10-30 | HC Wainwright & Co. | $25.00 | $18.0000 | Buy |
| 2025-10-28 | Bernstein | $14.0000 | $14.5000 | Market Perform |
| 2025-10-28 | RBC Capital | $21.00 | $14.0000 | Sector Perform |
| 2025-10-28 | Barclays | $26.00 | $24.0000 | Overweight |
| 2025-10-28 | JMP Securities | $33.0000 | $29.0000 | Market Outperform |
| 2025-10-28 | Wells Fargo | $45.00 | $17.0000 | Equal-Weight |
| 2025-10-27 | B of A Securities | $36.0000 | $30.0000 | Buy |
| 2025-10-27 | HC Wainwright & Co. | $30.0000 | $25.0000 | Buy |
| 2025-10-27 | Chardan Capital | $60.00 | $48 | Buy |
| 2025-10-06 | JMP Securities | $33.0000 | Market Outperform | |
| 2025-09-19 | HC Wainwright & Co. | $25.0000 | $30.0000 | Buy |
| 2025-09-19 | JMP Securities | Market Perform | ||
| 2025-08-13 | Guggenheim | $45.00 | $14.0000 | Buy |
| 2025-08-11 | Chardan Capital | $68.0000 | $60 | Buy |
| 2025-08-08 | HC Wainwright & Co. | $30.00 | $25.0000 | Buy |
| 2025-08-08 | Wells Fargo | $50.0000 | $45.0000 | Overweight |
| 2025-08-08 | RBC Capital | $25.0000 | $21.0000 | Outperform |
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $13.09 | -4.32% |
| 2026-06-01 | $13.15 | 0.50% |
| 2026-06-02 | $13.39 | 1.82% |
| 2026-06-03 | $13.54 | 1.09% |
| 2026-06-04 | $13.60 | 0.46% |
NTLA : Long term Intellia Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $13.80 , for 2027 May. is $17.36 , for 2030 May. is $18.29 , for 2031 May. is $18.34 , for 2035 May. is $10.17 , and for 2036 May. is $8.32.
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $13.80 | 0.88% |
| 2026 Jul. | $14.26 | 3.30% |
| 2026 Aug. | $14.93 | 4.74% |
| 2026 Sep. | $15.61 | 4.52% |
| 2026 Oct. | $16.13 | 3.39% |
| 2026 Nov. | $16.54 | 2.53% |
| 2026 Dec. | $16.85 | 1.83% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $17.07 | 1.32% |
| 2027 Feb. | $17.22 | 0.91% |
| 2027 Mar. | $17.31 | 0.47% |
| 2027 Apr. | $17.34 | 0.21% |
| 2027 May. | $17.36 | 0.12% |
| 2027 Jun. | $17.40 | 0.23% |
| 2027 Jul. | $17.45 | 0.27% |
| 2027 Aug. | $17.49 | 0.22% |
| 2027 Sep. | $17.52 | 0.18% |
| 2027 Oct. | $17.55 | 0.17% |
| 2027 Nov. | $17.58 | 0.18% |
| 2027 Dec. | $17.61 | 0.18% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $17.65 | 0.19% |
| 2028 Feb. | $17.68 | 0.21% |
| 2028 Mar. | $17.73 | 0.26% |
| 2028 Apr. | $17.78 | 0.28% |
| 2028 May. | $17.83 | 0.27% |
| 2028 Jun. | $17.87 | 0.26% |
| 2028 Jul. | $17.91 | 0.24% |
| 2028 Aug. | $17.95 | 0.22% |
| 2028 Sep. | $17.99 | 0.19% |
| 2028 Oct. | $18.01 | 0.13% |
| 2028 Nov. | $18.02 | 0.07% |
| 2028 Dec. | $18.03 | 0.04% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $18.04 | 0.08% |
| 2029 Feb. | $18.06 | 0.10% |
| 2029 Mar. | $18.08 | 0.09% |
| 2029 Apr. | $18.10 | 0.12% |
| 2029 May. | $18.13 | 0.15% |
| 2029 Jun. | $18.15 | 0.13% |
| 2029 Jul. | $18.17 | 0.12% |
| 2029 Aug. | $18.19 | 0.10% |
| 2029 Sep. | $18.21 | 0.09% |
| 2029 Oct. | $18.22 | 0.08% |
| 2029 Nov. | $18.24 | 0.07% |
| 2029 Dec. | $18.25 | 0.07% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $18.26 | 0.05% |
| 2030 Feb. | $18.27 | 0.05% |
| 2030 Mar. | $18.27 | 0.04% |
| 2030 Apr. | $18.28 | 0.04% |
| 2030 May. | $18.29 | 0.04% |
| 2030 Jun. | $18.30 | 0.04% |
| 2030 Jul. | $18.30 | 0.03% |
| 2030 Aug. | $18.31 | 0.03% |
| 2030 Sep. | $18.31 | 0.03% |
| 2030 Oct. | $18.32 | 0.03% |
| 2030 Nov. | $18.32 | 0.03% |
| 2030 Dec. | $18.33 | 0.02% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $18.33 | 0.02% |
| 2031 Feb. | $18.34 | 0.02% |
| 2031 Mar. | $18.34 | 0.02% |
| 2031 Apr. | $18.34 | 0.02% |
| 2031 May. | $18.34 | 0.01% |
| 2031 Jun. | $18.34 | 0.01% |
| 2031 Jul. | $18.34 | -0.01% |
| 2031 Aug. | $18.34 | -0.03% |
| 2031 Sep. | $18.33 | -0.07% |
| 2031 Oct. | $18.30 | -0.16% |
| 2031 Nov. | $18.24 | -0.32% |
| 2031 Dec. | $18.13 | -0.58% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $17.97 | -0.91% |
| 2032 Feb. | $17.75 | -1.20% |
| 2032 Mar. | $17.50 | -1.40% |
| 2032 Apr. | $17.24 | -1.51% |
| 2032 May. | $16.99 | -1.47% |
| 2032 Jun. | $16.77 | -1.28% |
| 2032 Jul. | $16.60 | -0.98% |
| 2032 Aug. | $16.53 | -0.48% |
| 2032 Sep. | $16.50 | -0.14% |
| 2032 Oct. | $16.48 | -0.16% |
| 2032 Nov. | $16.41 | -0.41% |
| 2032 Dec. | $16.28 | -0.76% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $16.12 | -1.03% |
| 2033 Feb. | $15.92 | -1.21% |
| 2033 Mar. | $15.70 | -1.36% |
| 2033 Apr. | $15.44 | -1.67% |
| 2033 May. | $15.16 | -1.81% |
| 2033 Jun. | $14.92 | -1.64% |
| 2033 Jul. | $14.71 | -1.37% |
| 2033 Aug. | $14.54 | -1.14% |
| 2033 Sep. | $14.40 | -0.97% |
| 2033 Oct. | $14.27 | -0.89% |
| 2033 Nov. | $14.15 | -0.87% |
| 2033 Dec. | $14.02 | -0.91% |
NTLA : Intellia Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $13.88 | -1.01% |
| 2034 Feb. | $13.72 | -1.14% |
| 2034 Mar. | $13.54 | -1.32% |
| 2034 Apr. | $13.33 | -1.54% |
| 2034 May. | $13.10 | -1.76% |
| 2034 Jun. | $12.85 | -1.87% |
| 2034 Jul. | $12.63 | -1.75% |
| 2034 Aug. | $12.43 | -1.54% |
| 2034 Sep. | $12.24 | -1.57% |
| 2034 Oct. | $12.01 | -1.86% |
| 2034 Nov. | $11.75 | -2.17% |
| 2034 Dec. | $11.47 | -2.36% |
NTLA : Intellia Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $11.19 | -2.46% |
| 2035 Feb. | $10.91 | -2.47% |
| 2035 Mar. | $10.65 | -2.43% |
| 2035 Apr. | $10.40 | -2.34% |
| 2035 May. | $10.17 | -2.24% |
| 2035 Jun. | $9.95 | -2.11% |
| 2035 Jul. | $9.75 | -1.99% |
| 2035 Aug. | $9.57 | -1.87% |
| 2035 Sep. | $9.40 | -1.77% |
| 2035 Oct. | $9.24 | -1.69% |
| 2035 Nov. | $9.09 | -1.62% |
| 2035 Dec. | $8.95 | -1.57% |
NTLA : Intellia Therapeutics stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $8.81 | -1.52% |
| 2036 Feb. | $8.68 | -1.48% |
| 2036 Mar. | $8.56 | -1.45% |
| 2036 Apr. | $8.44 | -1.43% |
| 2036 May. | $8.32 | -1.41% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2026 Jun. is $13.8004338255391 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2027 May. is $17.3616356011279 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2030 May. is $18.2889805766387 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2031 May. is $18.3438828260524 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2035 May. is $10.1653409305503 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2036 May. is $8.3172667992428
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AIPickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2027 May. is $17.3616356011279
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2026-05-28 is $13.6800003051758 and forecast for 2027 May. is $17.36, Intellia Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Intellia Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| NTLA stock price for 2026-05-08 | $14.09 | $14.07 | $13.73 | $14.55 |
| NTLA stock price for 2026-05-11 | $14.42 | $14.06 | $13.97 | $15.55 |
| NTLA stock price for 2026-05-12 | $13.99 | $14.34 | $13.52 | $14.50 |
| NTLA stock price for 2026-05-13 | $14.28 | $13.97 | $13.75 | $14.58 |
| NTLA stock price for 2026-05-14 | $13.09 | $14.16 | $12.91 | $14.38 |
| NTLA stock price for 2026-05-15 | $13.67 | $13.35 | $13.24 | $14.15 |
| NTLA stock price for 2026-05-18 | $12.69 | $13.78 | $12.11 | $13.88 |
| NTLA stock price for 2026-05-19 | $11.94 | $12.27 | $11.84 | $12.42 |
| NTLA stock price for 2026-05-20 | $12.26 | $11.91 | $11.79 | $12.53 |
| NTLA stock price for 2026-05-21 | $12.37 | $11.96 | $11.82 | $12.45 |
| NTLA stock price for 2026-05-22 | $12.60 | $12.40 | $12.35 | $12.89 |
| NTLA stock price for 2026-05-26 | $12.61 | $12.67 | $12.24 | $12.89 |
| NTLA stock price for 2026-05-27 | $13.44 | $12.60 | $12.51 | $13.75 |
| NTLA stock price for 2026-05-28 | $13.68 | $13.47 | $13.20 | $13.99 |